Target intelligence / Profile preview

Agkistrodon acutus venom snake C-type lectin-like protein (Snaclec)

Target
Snaclec
Molecular classification
C-type lectin-like protein, Snaclec, Heterodimeric protein
01

Overview

Agkistrodon acutus venom snake C-type lectin-like proteins, commonly referred to as snaclecs, are a major class of non-enzymatic proteins found in the venom of the long-nosed pit viper, also known as Deinagkistrodon acutus (UniProt, 2024). These proteins typically exist as heterodimers composed of alpha and beta subunits and exert their primary biological effects by targeting blood components, particularly platelets and coagulation factors (PubMed, PMID: 15617998). By binding with high affinity to receptors such as Glycoprotein Ib (GPIb), Glycoprotein VI (GPVI), or C-type lectin-like receptor 2 (CLEC-2), snaclecs can either trigger or block platelet aggregation, leading to the characteristic hematological disturbances seen in envenomation, such as thrombocytopenia and severe hemorrhage (PubMed, PMID: 22406181). In a clinical context, these proteins are the primary targets for specific antivenoms used to treat Agkistrodon acutus bites. Beyond their role in pathology, snaclecs are of significant interest in pharmacology as molecular tools for studying platelet physiology and as structural templates for the development of novel anti-thrombotic and anti-platelet therapeutic agents (PubMed, PMID: 11513578).

Other names
Snake C-type lectin-like proteinSnaclecAgkistrodon acutus CTLPAac-snaclecAgkistinDeinagkistrodon acutus C-type lectin
02

Mechanism of action

Binding to platelet receptors such as Glycoprotein Ib (GPIb) or Glycoprotein VI (GPVI) to either induce or inhibit platelet aggregation and interacting with coagulation factors to modulate the clotting cascade (PubMed, PMID: 15617998).

03

Biological functions

Platelet aggregation modulationBlood coagulation regulationCell adhesionLigand binding
04

Disease associations

Snakebite envenomationHemorrhageThrombocytopeniaThrombosis
05

Safety considerations

Risk of severe hemorrhageSystemic toxicityImmunogenicity of antivenomThrombocytopenia
06

Interacting drugs

Agkistrodon acutus antivenom
07

Biomarkers

Platelet countBleeding timeProthrombin time (PT)Activated partial thromboplastin time (aPTT)

Beyond the preview

Go deeper on Agkistrodon acutus venom snake C-type lectin-like protein (Snaclec).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Agkistrodon acutus venom snake C-type lectin-like protein (Snaclec).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call